IKS Healthcare Eyes $600 Mn TruBridge Acquisition, to Boost Healthcare Solutions

IKS Healthcare was founded in 2006 in India as an RCM provider. It handles key tasks like patient scheduling, insurance verification, and denial management for US healthcare providers. The company operates from India with a large workforce supporting American clients.

IKS Healthcare, backed by the Jhunjhunwala family, has entered advanced talks to acquire TruBridge for about $600 million.

TruBridge provides healthcare IT solutions and services to community hospitals and health systems across the US. Its offerings include electronic health records (EHR), patient engagement tools, and RCM software designed for smaller facilities.

If completed, this deal will become the company's largest purchase to date. It targets TruBridge's healthcare IT and revenue cycle management (RCM) services, which help hospitals manage billing and payments.

IKS Healthcare plans an all-cash offer funded by a $675 million debt facility from banks like Citi, Deutsche Bank, and JP Morgan. This financing covers the purchase price and refinances TruBridge's existing debt.

IKS Healthcare was founded in 2006 in India as an RCM provider. It handles key tasks like patient scheduling, insurance verification, and denial management for US healthcare providers. The company operates from India with a large workforce supporting American clients.

TruBridge serves acute care hospitals with full-suite IT needs, while IKS Healthcare focuses on physicians' offices and back-office administrative tasks.

The Jhunjhunwala family has propelled IKS Healthcare from an initial INR 25 crore stake to Rs 13,250 crore, a 530x return through its public market rise. This shows strong confidence in its US healthcare expansion.

A Rs 500 crore block deal last year has briefly dipped shares by 4% yet strengthened investor interest amid IKS's $3.17 billion NSE valuation. It cements the family's role in its growth strategy.

Last year, IKS Health partnered with GI Alliance, the largest US independent gastroenterology group, to deploy AI-enabled RCM solutions integrating technology and human expertise for optimized workflows and clinical enablement.

This follows prior moves like acquiring AQuity Solutions in 2023 for AI datasets and investments in Abridge and Sift Healthcare, accelerating IKS's proprietary AI in RCM. These steps position IKS valued at $3.17 billion on NSE for deeper US penetration, blending TruBridge's hospital IT strengths with its ambulatory focus.

Stay tuned for more such updates on Digital Health News